Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, responded earlier this year to an urgent request from their client partner, Alexion Pharmaceuticals, Inc., a global biotechnology company, for packaging and distribution of Soliris (eculizumab) for patients with STEC-HUS during the E. coli outbreak in Germany earlier this year.

21 Nov 2011

Puritan Medical Products establishes new diagnostic division

Responding to a fast-growing need for specialized diagnostic collection and transport systems, Puritan Medical Products LLC has established a new diagnostic division to better serve its customers throughout the world.

19 Nov 2011

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

Eli Lilly and Company today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tuberculosis, including multidrug-resistant strains known as MDR-TB.

17 Nov 2011

Par Pharmaceutical acquires Anchen

Par Pharmaceutical Companies, Inc. today announced that it has completed its acquisition of Anchen Pharmaceuticals, a privately-held specialty pharmaceutical company focused on developing and commercializing extended release and niche generic products.

17 Nov 2011

Boehringer Ingelheim bolsters drug discovery, development with $350M in capital investments

Boehringer Ingelheim Pharmaceuticals announced today that it has made more than $350 million worth of capital investments throughout its U.S. operations this year, in order to further bolster its drug discovery, development and manufacturing capabilities.

16 Nov 2011

Midatech receives Swissmedic approval to start trial of insulin-coated gold nanoparticle

Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.

15 Nov 2011

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

15 Nov 2011

Corgenix first quarter total revenues increase 10.1% to $2.18 million

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, today filed its fiscal quarter Form 10-Q and reported financial results.

14 Nov 2011

Simcere third quarter total revenue decreases 8.9% to RMB501.0 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended September 30, 2011.

14 Nov 2011

Leonardo Biosystems receives second investment from Texas Emerging Technology Fund

Leonardo Biosystems, Inc., an emerging drug delivery company, announced today that it has received the second half of a $2.5 million award from the Texas Emerging Technology Fund (TETF). The initial investment tranche was received in April 2010.

14 Nov 2011

Sinovac third quarter sales increase 60.8% to $15.4 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.

14 Nov 2011

TPI first quarter revenue decreases 20.5% to $17.5 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (TCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the first quarter of Fiscal Year 2012.

14 Nov 2011

New insight into how ammonia is formed

For the past 100 years, the Haber-Bosch process has been used to convert atmospheric nitrogen into ammonia, which is essential in the manufacture of fertilizer. Despite the longstanding reliability of the process, scientists have had little understanding of how it actually works. But now a team of chemists, led by Patrick Holland of the University of Rochester, has new insight into how the ammonia is formed.

14 Nov 2011

IVI receives WHO prequalification for new oral cholera vaccine

Shanchol-, a new oral cholera vaccine developed through the International Vaccine Institute (IVI), an international organization established by the United Nations and based in Seoul, recently received prequalification from the World Health Organization.

13 Nov 2011

Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz

Bristol-Myers Squibb Company today announced a technology transfer agreement with the Brazilian Ministry of Health to expand access to Reyataz (atazanavir sulfate) in Brazil.

13 Nov 2011

FDA warnings to retailers selling cigarettes to under-18s

The federal health regulators have lashed out at some 1,200 retailers for unlawfully selling cigarettes and other tobacco products to children under 18.

13 Nov 2011

Actavis begins shipping Morphine Sulfate Extended-Release Capsules

Actavis, an international generic pharmaceutical company, today announced that it has begun shipping Morphine Sulfate Extended-Release Capsules, USP CII, an authorized generic of KADIAN.

11 Nov 2011

NeoStem third quarter revenues increase to $17.8 million

NeoStem, Inc., an international biopharmaceutical company with a focus on cell based therapeutics development, today reported third quarter results and recent progress in its business.

11 Nov 2011

FDA licenses NYBC's HEMACORD stem cell product

The Food and Drug Administration has licensed HEMACORD for allogeneic hematopoietic (blood-forming) stem cell transplantation, the first such approval of a stem cell product in the world.

11 Nov 2011

ArQule, Daiichi Sankyo enter license agreement for development of new AKT inhibitor

ArQule, Inc. and Daiichi Sankyo, Co. Ltd. announced today the execution of a license agreement for the development of a new AKT inhibitor called ARQ 092, the first compound to emerge from the companies' November 2008 agreement to collaborate on research utilizing the AKIP (ArQule Kinase Inhibitor Platform) technology to generate novel, selective and potent small molecule kinase inhibitors.

10 Nov 2011

Manufacturing News and Research

Further Reading

Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak

Puritan Medical Products establishes new diagnostic division

Eli Lilly provides $4M in additional funding to IDRI for new TB therapies

Par Pharmaceutical acquires Anchen

Boehringer Ingelheim bolsters drug discovery, development with $350M in capital investments

Midatech receives Swissmedic approval to start trial of insulin-coated gold nanoparticle

Scil Proteins completes manufacturing agreement with Lundbeck

Corgenix first quarter total revenues increase 10.1% to $2.18 million

Simcere third quarter total revenue decreases 8.9% to RMB501.0 million

Leonardo Biosystems receives second investment from Texas Emerging Technology Fund

Sinovac third quarter sales increase 60.8% to $15.4 million

TPI first quarter revenue decreases 20.5% to $17.5 million

New insight into how ammonia is formed

IVI receives WHO prequalification for new oral cholera vaccine

Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz

FDA warnings to retailers selling cigarettes to under-18s

Actavis begins shipping Morphine Sulfate Extended-Release Capsules

NeoStem third quarter revenues increase to $17.8 million

FDA licenses NYBC's HEMACORD stem cell product

ArQule, Daiichi Sankyo enter license agreement for development of new AKT inhibitor

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News